1. Home
  2. AMPY vs LUCD Comparison

AMPY vs LUCD Comparison

Compare AMPY & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplify Energy Corp.

AMPY

Amplify Energy Corp.

HOLD

Current Price

$3.99

Market Cap

215.9M

Sector

Energy

ML Signal

HOLD

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.05

Market Cap

198.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPY
LUCD
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.9M
198.4M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
AMPY
LUCD
Price
$3.99
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
942.0K
1.6M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
232.26
16.67
EPS
N/A
N/A
Revenue
$208,637,000.00
$4,346,000.00
Revenue This Year
N/A
$115.58
Revenue Next Year
$23.83
$130.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.00
52 Week Low
$3.12
$0.90
52 Week High
$6.79
$1.63

Technical Indicators

Market Signals
Indicator
AMPY
LUCD
Relative Strength Index (RSI) 35.74 53.74
Support Level $3.86 $1.02
Resistance Level $4.92 $1.12
Average True Range (ATR) 0.15 0.05
MACD 0.03 0.01
Stochastic Oscillator 27.64 75.47

Price Performance

Historical Comparison
AMPY
LUCD

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: